Patient Guide: Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 11 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04515238
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Lymphoid Leukemia
Phase: PHASE2

Find a Study Location Near You

This study is available at 11 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Augsburg,
  • Esslingen,
  • Hamm,
  • • And 8 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily